Setting International Standards in
Analysing Patient-Reported Outcomes
and Quality of Life Endpoints


The SISAQOL-IMI consortium is set up with 41 stakeholders from more than 15 different countries worldwide to ensure that the developed guidelines address the needs of various stakeholders (regulators, health technology assessment bodies, payers, clinicians, methodological and applied statisticians, PRO experts, industry, and patient organisations).

Want to know more about SISAQOL-IMI?